LTR Pharma Statistics

Total Valuation

LTR Pharma has a market cap or net worth of AUD 81.80 million. The enterprise value is 56.02 million.

Market Cap	81.80M
Enterprise Value	56.02M

Important Dates

The last earnings date was Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

LTR Pharma has 181.78 million shares outstanding. The number of shares has increased by 23.89% in one year.

Current Share Class	181.78M
Shares Outstanding	181.78M
Shares Change (YoY)	+23.89%
Shares Change (QoQ)	-0.08%
Owned by Insiders (%)	5.41%
Owned by Institutions (%)	0.70%
Float	106.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	72.30
PB Ratio	3.04
P/TBV Ratio	3.04
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-6.26
EV / Sales	49.51
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-8.04

Financial Position

The company has a current ratio of 57.47

Current Ratio	57.47
Quick Ratio	56.70
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-425,417.91

Financial Efficiency

Return on equity (ROE) is -29.27% and return on invested capital (ROIC) is -20.00%.

Return on Equity (ROE)	-29.27%
Return on Assets (ROA)	-19.71%
Return on Invested Capital (ROIC)	-20.00%
Return on Capital Employed (ROCE)	-36.42%
Weighted Average Cost of Capital (WACC)	25.63%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.04
Inventory Turnover	409.79

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.05% in the last 52 weeks. The beta is 3.89, so LTR Pharma's price volatility has been higher than the market average.

Beta (5Y)	3.89
52-Week Price Change	-21.05%
50-Day Moving Average	0.55
200-Day Moving Average	0.47
Relative Strength Index (RSI)	40.53
Average Volume (20 Days)	207,249

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LTR Pharma had revenue of AUD 1.13 million and -8.95 million in losses. Loss per share was -0.05.

Revenue	1.13M
Gross Profit	-3.40M
Operating Income	-9.78M
Pretax Income	-8.95M
Net Income	-8.95M
EBITDA	-9.78M
EBIT	-9.78M
Loss Per Share	-0.05

Full Income Statement

Balance Sheet

The company has 25.78 million in cash and n/a in debt, giving a net cash position of 25.78 million or 0.14 per share.

Cash & Cash Equivalents	25.78M
Total Debt	n/a
Net Cash	25.78M
Net Cash Per Share	0.14
Equity (Book Value)	26.86M
Book Value Per Share	0.15
Working Capital	25.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.96 million and capital expenditures -4,505, giving a free cash flow of -6.96 million.

Operating Cash Flow	-6.96M
Capital Expenditures	-4,505
Free Cash Flow	-6.96M
FCF Per Share	-0.04

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-864.79%
Pretax Margin	-791.01%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LTR Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-23.89%
Shareholder Yield	-23.89%
Earnings Yield	-10.94%
FCF Yield	-8.51%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LTR Pharma has an Altman Z-Score of 114.92 and a Piotroski F-Score of 2.

Altman Z-Score	114.92
Piotroski F-Score	2